40 results
8-K
EX-10.1
AGRX
Agile Therapeutics Inc
25 May 23
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
5:25pm
, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery
8-K
EX-10.1
AGRX
Agile Therapeutics Inc
8 Jul 22
Agile Therapeutics Announces Pricing of
5:16pm
the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident
8-K
EX-1.1
zxx7jm
27 Apr 22
Agile Therapeutics Announces 1-FOR-40 Reverse Stock Split
7:21am
8-K
EX-10.1
5x74640 za
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
8-K
EX-1.1
9k870r
10 Jan 22
Entry into a Material Definitive Agreement
8:05am
8-K
EX-1.1
p8gdatw9
8 Oct 21
Agile Therapeutics Appoints Josephine Torrente to its Board of Directors
5:23pm
8-K
EX-1.1
tym gbm4js4ep3ib0xz3
18 Mar 21
Entry into a Material Definitive Agreement
5:13pm
8-K
EX-1.1
k1x4c1
21 Feb 20
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
4:46pm
8-K
EX-1.1
c2pqmv09yuyryx
8 Nov 19
Entry into a Material Definitive Agreement
4:38pm
8-K
EX-1.1
ojtqo
2 Aug 19
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
4:50pm
8-K
EX-10.1
ybea7i97fh0d9zt5xk
4 Mar 19
Agile Therapeutics Announces $7.8 Million Private Placement
5:27pm
8-K
EX-1.1
qk9o9
23 Jan 19
Entry into a Material Definitive Agreement
8:04am